Rhizome AI

Rhizome AI (YC W26) is building Glean for life sciences. We will universally organize and make accessible the world's life science information for agents so they can help us 10x the number of therapies coming to market.

Chetan (our CEO)'s last role was building an AI inference platform for drug discovery at a company with 140m raised. He saw the incredibly things that were becoming possible to come up with drug candidates, but it was clear that the bottlenecks were only getting more severe on the path for these candidates to come to market.

We've started this journey by indexing and powering retrieval across >3 TB of public regulatory and clinical data. Rhizome Ask - our regulatory agent - is helping dozens of companies understand exactly what the FDA or EMA expects. This is critical to prepare for regulator meetings, write documentation, and automate compliance activities. ChatGPT and Claude do poorly in these scenarios, they just don't have the...